Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EVG NASDAQ:MTFB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVGEaton Vance Short Duration Diversified Income Fund$11.25+0.5%$11.10$10.25▼$11.45N/AN/A40,591 shs52,281 shsMTFBMotif Bio$0.11$0.10$0.08▼$11.50N/AN/AN/A867,698 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVGEaton Vance Short Duration Diversified Income Fund0.00%-0.75%+2.18%+4.60%+1.67%MTFBMotif Bio0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/AN/AN/AN/AN/AN/AMTFBMotif BioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVGEaton Vance Short Duration Diversified Income Fund 0.00N/AN/AN/AMTFBMotif Bio 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVGEaton Vance Short Duration Diversified Income Fund$13.65MN/AN/AN/AN/AN/AMTFBMotif BioN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVGEaton Vance Short Duration Diversified Income FundN/AN/A0.00∞N/AN/AN/AN/AN/AMTFBMotif BioN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVGEaton Vance Short Duration Diversified Income Fund$0.988.71%N/AN/AN/AMTFBMotif BioN/AN/AN/AN/AN/ALatest PYC, BSFA, EVG, and MTFB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/4/2025EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07438.2%8/15/20258/15/20258/29/20257/2/2025EVGEaton Vance Short Duration Diversified Income Fund--$0.07438.2%7/15/20257/15/20257/31/20256/3/2025EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07378.5%6/16/20256/16/20256/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVGEaton Vance Short Duration Diversified Income FundN/AMTFBMotif BioN/AInsider OwnershipCompanyInsider OwnershipEVGEaton Vance Short Duration Diversified Income FundN/AMTFBMotif BioN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/ANot OptionableMTFBMotif Bio7N/AN/ANot OptionablePYC, BSFA, EVG, and MTFB HeadlinesRecent News About These CompaniesRice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulationApril 12, 2024 | tmcnet.comRBM17 (F-5) ACFebruary 24, 2024 | labroots.comLSmall-molecule A485 mobilizes white blood cells on demandFebruary 3, 2024 | msn.comROBIT PLC’S FINANCIAL INFORMATION AND ANNUAL GENERAL MEETING IN 2024November 3, 2023 | finance.yahoo.com4GLOBAL plc's (LON:4GBL) Stock Is Going Strong: Have Financials A Role To Play?August 9, 2023 | finance.yahoo.comIs There An Opportunity With Stelrad Group PLC's (LON:SRAD) 44% Undervaluation?August 2, 2023 | finance.yahoo.comDAVA - Endava plcJune 13, 2023 | finance.yahoo.comLacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/SMay 25, 2023 | finance.yahoo.comInovyn launches world’s first bio-attributed PVCMay 10, 2023 | plasticstoday.comPCushman & Wakefield PLC CWK Stock QuoteApril 27, 2023 | morningstar.comMThe Dizzying ‘Mrs. Davis’ Refuses to Settle for Simple WeirdnessApril 23, 2023 | thedailybeast.comTIneos Styrolution Launches World’s First Fully Bio-Attributed ABSMarch 16, 2023 | plasticstoday.comPEvli Plc: Financial Statements Bulletin January-December 2022February 22, 2023 | finance.yahoo.comEnzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2029February 13, 2023 | marketwatch.comLuciferase Assay Kits Market Trends and Opportunities and Forecast to 2028 with Top Countries DataFebruary 13, 2023 | marketwatch.comAccenture PLC Cl AFebruary 10, 2023 | wsj.comConsti Plc's financial reporting and Annual General Meeting in 2023November 16, 2022 | finance.yahoo.comInternational Space Station’s BFF 3D Prints Human TissueNovember 4, 2022 | plasticstoday.comPImmunoprotein Reagents and Assay Kits Market Research on Present State and Future Growth Prospects of Key Players, Forecast by 2022 To 2028October 20, 2022 | marketwatch.comThe race to native code execution in PLCs: using RCE to uncover Siemens SIMATIC S7-1200/1500 hardcoded cryptographic keysOctober 14, 2022 | itwire.comIMedia Sentiment Over TimePYC, BSFA, EVG, and MTFB Company DescriptionsEaton Vance Short Duration Diversified Income Fund NYSE:EVG$11.24 +0.06 (+0.49%) Closing price 08/22/2025 03:58 PM EasternExtended Trading$11.24 0.00 (0.00%) As of 08/22/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Eaton Vance Short Duration Diversified Income Fund is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It primarily invests in senior, secured floating-rate loans, bank deposits denominated in foreign currencies, debt obligations of foreign governmental and corporate issuers, and mortgage-backed securities. The fund invests in fixed income securities operating across diversified sectors. It invests in fixed income securities with an average duration of 1.76 years and an average credit quality of least BBB. The fund benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. It was formerly known as Eaton Vance Low Duration Diversified Income Fund. Eaton Vance Short Duration Diversified Income Fund was formed on February 28, 2005 and is domiciled in the United States.Motif Bio NASDAQ:MTFBMotif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access